KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Ginkgo Bioworks Holdings (DNA) Receivables - Net (2020 - 2025)

Ginkgo Bioworks Holdings' Receivables - Net history spans 6 years, with the latest figure at $229000.0 for Q4 2025.

  • For Q4 2025, Receivables - Net fell 60.92% year-over-year to $229000.0; the TTM value through Dec 2025 reached $229000.0, down 60.92%, while the annual FY2025 figure was $229000.0, 60.92% down from the prior year.
  • Receivables - Net reached $229000.0 in Q4 2025 per DNA's latest filing, down from $21.4 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $171.6 million in Q2 2022 to a low of $229000.0 in Q4 2025.
  • Average Receivables - Net over 5 years is $46.1 million, with a median of $21.8 million recorded in 2025.
  • Peak YoY movement for Receivables - Net: plummeted 99.56% in 2024, then surged 7006.22% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $131.5 million in 2021, then crashed by 98.82% to $1.6 million in 2022, then plummeted by 52.37% to $742000.0 in 2023, then fell by 21.02% to $586000.0 in 2024, then tumbled by 60.92% to $229000.0 in 2025.
  • Per Business Quant, the three most recent readings for DNA's Receivables - Net are $229000.0 (Q4 2025), $21.4 million (Q3 2025), and $22.2 million (Q2 2025).